<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03404492</url>
  </required_header>
  <id_info>
    <org_study_id>17-PP-09</org_study_id>
    <nct_id>NCT03404492</nct_id>
  </id_info>
  <brief_title>Effects of Cardiorespiratory Rehabilitation on the Right Ventricle in Pulmonary Hypertension</brief_title>
  <acronym>Rehab-HTP</acronym>
  <official_title>Effects of Cardiorespiratory Rehabilitation on the Right Ventricle in Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical improvement has been demonstrated after cardiorespiratory rehabilitation in patients&#xD;
      with pulmonary hypertension. Rehabilitation is therefore now part of the recommendations for&#xD;
      good practice. However, no data is available to elucidate the mechanism of this improvement:&#xD;
      an improvement in myocardial reserve or an improvement in peripheral muscular capacity? The&#xD;
      main objective of this study is to evaluate the difference in right ventricular contractile&#xD;
      reserve before and after cardiorespiratory rehabilitation during stress ultrasound in&#xD;
      pulmonary hypertension in 10 patients with pulmonary hypertension.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 12, 2018</start_date>
  <completion_date type="Anticipated">April 12, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of the subpulmonary ITS at effort &gt;20% (presence of a right ventricular contractile reserve) defined by the improvement of the ITS or integral subpulmonary time-speed)</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Patients with pulmonary hypertension</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stress echocardiography</intervention_name>
    <description>A stress echocardiography will be performed in addition to the traditional patient care</description>
    <arm_group_label>Patients with pulmonary hypertension</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Major patients&#xD;
&#xD;
          -  Proven pulmonary hypertension: PAPm ≥ 25mmHg, known PH&#xD;
&#xD;
          -  Group 1,3,4 or 5 of the pulmonary hypertension classification&#xD;
&#xD;
          -  Clinical stability &gt; 1 month clinically determined by clinician&#xD;
&#xD;
          -  NYHA II or III class&#xD;
&#xD;
          -  Signature of informed consent form following appropriate information&#xD;
&#xD;
          -  Patient affiliated to the Social Security System&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Associated left heart disease&#xD;
&#xD;
          -  Complex congenital heart disease&#xD;
&#xD;
          -  Acoustic window which does not allow the echocardiography to be performed correctly&#xD;
&#xD;
          -  Permanent cardiac arrhythmia&#xD;
&#xD;
          -  NYHA IV class and NYHA I class&#xD;
&#xD;
          -  Inability to perform at least a minimal effort on an ergometer&#xD;
&#xD;
          -  Unstabilized acute coronary syndrome&#xD;
&#xD;
          -  Compensatory heart failure&#xD;
&#xD;
          -  Disturbances of ventricular rhythm veins, may not be narrowed.&#xD;
&#xD;
          -  Prevalence of high-risk embolic intracardiac thrombus&#xD;
&#xD;
          -  Prevalence of high-risk embolic intracardiac thrombus&#xD;
&#xD;
          -  Preference of a medium to high abundance peericard-like thinning.&#xD;
&#xD;
          -  Venous thromboembolic venous thromboembolic disease (&gt; 3 months)&#xD;
&#xD;
          -  Left ventricular ejector obstruction (severe and/or symptomatic)&#xD;
&#xD;
          -  Persons under guardianship, under curatorship, protected by law&#xD;
&#xD;
          -  Persons deprived of their liberty&#xD;
&#xD;
          -  Pregnant and parturient women&#xD;
&#xD;
          -  Major not able or unable to express consent&#xD;
&#xD;
          -  Minors&#xD;
&#xD;
          -  Inability to perform cardiac rehabilitation&#xD;
&#xD;
          -  Modynamic instability&#xD;
&#xD;
          -  Follow-up impossible for geographical or psychological reasons&#xD;
&#xD;
          -  Inadequate command of the French language&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela MOCERI, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nice</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pamela MOCERI, PH</last_name>
    <phone>+33 (0)4.92.03.77.34</phone>
    <email>moceri.p@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Pasteur</name>
      <address>
        <city>Nice</city>
        <zip>06002</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela MOCERI, PH</last_name>
      <phone>+33 (0)4.92.03.77.34</phone>
      <email>moceri.p@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>January 12, 2018</study_first_submitted>
  <study_first_submitted_qc>January 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2018</study_first_posted>
  <last_update_submitted>June 14, 2018</last_update_submitted>
  <last_update_submitted_qc>June 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

